NAD+ metabolism-based immunoregulation and therapeutic potential

Jiankai Fang,Wangwang Chen,Pengbo Hou,Zhanhong Liu,Muqiu Zuo,Shisong Liu,Chao Feng,Yuyi Han,Peishan Li,Yufang Shi,Changshun Shao
DOI: https://doi.org/10.1186/s13578-023-01031-5
2023-05-10
Abstract:Nicotinamide adenine dinucleotide (NAD+) is a critical metabolite that acts as a cofactor in energy metabolism, and serves as a cosubstrate for non-redox NAD+-dependent enzymes, including sirtuins, CD38 and poly(ADP-ribose) polymerases. NAD+ metabolism can regulate functionality attributes of innate and adaptive immune cells and contribute to inflammatory responses. Thus, the manipulation of NAD+ bioavailability can reshape the courses of immunological diseases. Here, we review the basics of NAD+ biochemistry and its roles in the immune response, and discuss current challenges and the future translational potential of NAD+ research in the development of therapeutics for inflammatory diseases, such as COVID-19.
What problem does this paper attempt to address?